0
Preventing Overdoses and Saving Lives Act of 2021
12/30/2022, 11:18 AM
Summary of Bill HR 5224
One key provision of the bill is the expansion of access to naloxone, a medication that can reverse the effects of an opioid overdose. The bill allocates funding to increase the availability of naloxone in communities across the country, including in schools, first responder agencies, and community organizations. This provision is aimed at ensuring that individuals at risk of overdose have access to this life-saving medication.
Additionally, the bill increases funding for substance use disorder treatment programs, including medication-assisted treatment (MAT) and counseling services. These programs are crucial for individuals struggling with opioid addiction to receive the support they need to recover and prevent future overdoses. Another important aspect of the bill is the improvement of data collection on overdose deaths. By enhancing data collection methods and sharing information across agencies, the bill aims to provide a more comprehensive understanding of the opioid crisis and identify areas where additional resources and interventions are needed. Overall, the Preventing Overdoses and Saving Lives Act of 2021 is a comprehensive approach to addressing the opioid crisis in the United States. By expanding access to overdose reversal medications, increasing funding for treatment programs, and improving data collection on overdose deaths, the bill seeks to prevent overdoses and save lives in communities across the country.
Congressional Summary of HR 5224
Preventing Overdoses and Saving Lives Act of 2021
This bill establishes a grant program for states, Indian tribes, and territories to respond to the opioid crisis. In awarding the grants, the Department of Health and Human Services (HHS) must give priority to recipients with the highest opioid dispensing rates.
Recipients must use at least 20% of grant funds to implement a program that requires a prescription for an opioid overdose reversal drug along with an opioid prescription if (1) a patient is prescribed benzodiazepines, medication-assisted treatment, or high-dose opioids; or (2) the prescriber has reason to know of the patient's history with substance use disorders. As part of this program, recipients must also require continuing education on opioid-prescribing practices for prescribers and on recognizing opioid overdose fatalities for coroners.
Recipients must use the remaining funds to develop a strategic plan for the jurisdiction's response to the opioid crisis.





